CURE® highlights some top stories from the ASH Annual Meeting, focusing on B-cell acute lymphoblastic leukemia, multiple ...

Equecabtagene autoleucel produced “remarkable” responses in patients whose disease progressed after prior BCMA CAR T-cell therapy, researchers reported.

After hours: January 6 at 6:49:21 PM EST Loading Chart for CRS ...

Weighing the Risk of Infection Versus the Benefits of Social Interactions in Our Pediatric Oncology Patients The three-center Mayo Clinic experience with ... No patients received prophylactic ...

Among patients with heavily pretreated chronic lymphocytic leukemia, treatment with Epkinly monotherapy showed deep responses ...

ActiGraph, the global leader in wearable digital health technology for clinical research and development, has announced the acquisition of Biofourmis Connect, a division of Biofourmis that delivers an ...

Panelist discusses how talquetamab’s step-up dosing strategy aims to mitigate cytokine release syndrome, a common immunologic toxicity. The reported grade 1 CRS with altered taste and dry mouth ...

CAR T-cell therapy represents a groundbreaking advancement in the field of oncology, particularly in the treatment of certain types of blood cancers such as leukemia and lymphoma. This innovative ...

More than 66,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

This is also called stage 4c bowel cancer. Surgery combined with chemotherapy is also called cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). It involves: the ...